| Abstrakt: |
Although FSP1 has been considered as an attractive drug target for cancer therapy, in vivo efficacious FSP1 inhibitors have been lacking. Keywords: Cancer; Cancer Therapy; Drugs and Therapies; Health and Medicine; Helmholtz Munich (Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur; Oncology EN Cancer Cancer Therapy Drugs and Therapies Health and Medicine Helmholtz Munich (Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur Oncology 568 568 1 07/10/23 20230711 NES 230711 2023 JUL 11 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- A team of researchers led by Dr. Marcus Conrad from Helmholtz Munich discovered a novel anti-cancer drug, called icFSP1, which sensitizes cancer cells to ferroptosis. Cancer, Cancer Therapy, Drugs and Therapies, Health and Medicine, Helmholtz Munich (Helmholtz Zentrum Munchen Deutsches Forschungszentrum fur, Oncology. [Extracted from the article] |
